4 | SEC Filings Hub

Filing metadata

Accession number: 0001562180-24-001293
Form type: Form 4
Filer: EyePoint Pharmaceuticals, Inc.
CIK: CIK 1314102
Filed: Feb 13, 2024
Reporting period: Feb 09, 2024
Description: Insider transaction

Documents

0001562180-24-001293-index.htm

Complete submission

0001562180-24-001293.txt

directory listing

Filed by

EyePoint Pharmaceuticals, Inc.